Division of Cardiology, Department of Pediatrics, Columbia University Vagelos College of Physicians and Surgeons and NewYork-Presbyterian Morgan Stanley Children's Hospital, New York, NY, USA.
Division of Cardiology, The Heart Institute, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
Pediatr Cardiol. 2024 Apr;45(4):829-839. doi: 10.1007/s00246-024-03424-w. Epub 2024 Feb 29.
The utility of troponin levels, including high sensitivity troponin T (hs-TnT), after orthotopic heart transplant (OHT) is controversial. Conflicting data exist regarding its use as a marker of acute rejection. Few studies have examined possible associations of hs-TnT levels immediately after OHT with metrics of intensive care unit (ICU) resource utilization or risk of acute rejection. We performed a retrospective cohort chart review including all OHT recipients < 20 years of age at our center between June 2019 and December 2022. Patients were divided into two groups based on supra- or sub-median initial hs-TnT levels (median 3462.5 ng/L). Primary outcome was days requiring ICU-level care, secondary outcomes included days intubated, days requiring positive pressure ventilation (PPV), days on inotropic medications, actual ICU length of stay, Vasoactive Inotrope Scores (VIS) on postoperative days (POD) 0 through 7, and acute rejection at 30 days and one year after OHT. Patients with higher hs-TnT required ICU level care for longer [13.5 (10-17.5) vs. 9.5 (8-12) days, p = 0.01] and spent more days intubated [6 (4-7) vs. 3 (3-5) days, p < 0.001], on PPV [9 (6-15) vs. 6 (5-8.5) days, p = 0.02], and on inotropes [11 (9-14) vs. 8 (7-11) days, p = 0.025]. VIS was only different between groups on POD7 [5 (3-7) vs. 3 (0-5), p = 0.04]. There was no difference in rejection between the groups. Higher hs-TnT immediately following pediatric OHT may predict higher ICU resource utilization, despite no difference in VIS, although it does not predict acute rejection in the first year after OHT.
在原位心脏移植(OHT)后,肌钙蛋白水平(包括高敏肌钙蛋白 T(hs-TnT))的实用性存在争议。关于其作为急性排斥标志物的使用存在相互矛盾的数据。很少有研究检查 OHT 后即刻 hs-TnT 水平与重症监护病房(ICU)资源利用或急性排斥风险的指标之间可能存在的关联。我们对 2019 年 6 月至 2022 年 12 月期间在我们中心接受 OHT 的所有年龄<20 岁的患者进行了回顾性队列图表审查。根据初始 hs-TnT 水平的中位数(3462.5ng/L),将患者分为两组:中位数以上或以下。主要结果是需要 ICU 级护理的天数,次要结果包括插管天数、需要正压通气(PPV)的天数、使用儿茶酚胺药物的天数、实际 ICU 住院时间、术后第 0 天至第 7 天的血管活性肠肽评分(VIS)以及 OHT 后 30 天和 1 年的急性排斥反应。hs-TnT 较高的患者需要 ICU 级护理的时间更长[13.5(10-17.5)比 9.5(8-12)天,p=0.01],插管时间更长[6(4-7)比 3(3-5)天,p<0.001],需要接受 PPV 的时间更长[9(6-15)比 6(5-8.5)天,p=0.02],使用儿茶酚胺药物的时间更长[11(9-14)比 8(7-11)天,p=0.025]。两组在 POD7 时 VIS 仅存在差异[5(3-7)比 3(0-5),p=0.04]。两组之间的排斥反应没有差异。尽管在 OHT 后第一年,hs-TnT 水平升高并不预示急性排斥反应,但它可能预示着儿科 OHT 后更高的 ICU 资源利用。